Preparation and Evaluation of MPEG-PCL Polymeric Nanoparticles Against Gastric Cancer

Abstract

This paper provides a new treatment for gastric cancer with a new OMT delivery system. We synthesized MPEG-PCL, an amphiphilic polymer, to construct a nanoparticle encapsulated OMT by pH gradient method, and then examined the nanodrug’s therapeutic efficacy. An integral analytical method was used to characterize the structure of MPEG-PCL. The single factor method and orthogonal test were utilized to investigate the optimum preparation process. The morphology and average size of the OMT-NPs were analyzed by transmission electron microscopy and Zetasizer. CCK-8 assay and confocal fluorescent microscope were used to study the inhibitory effect on SGC-7901 gastric cancer cells. The average size of nanoparticles was 95.86±1.54 nm. The maximum encapsulation efficiency of OMT was 46.84±4.37%, while the drug loading content was 8.89±1.09%. The cumulative release of nanoparticles was 73.07±1.5%, inspected through dynamic dialysis in vitro. Compared with free OMT, OMT-NPs showed enhanced cytotoxic effects in SGC-7901 cells. The nanoparticles could efficiently deliver the OMT into the cancer cells and release it. The OMT delivery system prepared in this paper provides a potential platform for the treatment of gastric cancer.

Keywords

MPEG-PCL / nanoparticles / oxymatrine / gastric cancer

References

[1] Corso S, Ghiso E, Cepero V, et al. Activation of HER Family Members in Gastric Carcinoma Cells Mediates Resistance to MET Inhibition[J]. Molecular Cancer, 2010, 9(1): 121-133.

[2] Hu Y, Zhao G, Zheng H. Therapeutic Effects of Laparotomy and Lapa-roscopic Surgery on Patients with Gastric Cancer[J]. Pakistan Journal of Medical Sciences, 2015, 31(3): 572-575.

[3] Zheng L, Wang L, Ajani J, et al. Molecular Basis of Gastric Cancer Development and Progression[J]. Gastric Cancer, 2004, 7(2): 61-77.

[4] Zhang J, Wang J, Guo Q, et al. LCH-7749944, A Novel and Potent p21-activated Kinase 4 Inhibitor, Suppresses Proliferation and Invasion in Human Gastric Cancer Cells[J]. Cancer Letters, 2012, 317(1): 24-32.

[5] Lu WW, Zhang R, Zhu JS, et al. Oxymatrine and Cancer Therapy[J]. European Journal of Inflammation, 2015, 13(3): 148-153.

[6] Yan L, Bi T, Wei D, et al. Oxymatrine Synergistically Enhances the Inhibitory Effect of 5-fluorouracil on Hepatocellular Carcinoma in vitro and in vivo[J]. Tumor Biology, 2016, 37(6): 7 589-7 597.

[7] Pei Z, Zeng J, Gao Y, et al. Oxymatrine Inhibits the Proliferation of CaSki Cells Via Downregulating HPV16E7 Expression[J]. Oncology Reports, 2016, 36(1): 291-298.

[8] Yan L, Bi T, Zheng W, et al. Oxymatrine Synergistically Enhances Antitumor Activity of Oxaliplatin in Colon Carcinoma Through PI3K/AKT/mTOR Pathway[J]. Apoptosis An International Journal on Programmed Cell Death, 2016, 21(12): 1 398-1 408.

[9] Zhang R, Hu S, Chen X, et al. Screening and Research of Anti-Cancer Matrine Components Based on Hollow Fiber Cell Fishing with High-Performance Liquid Chromatography[J]. Chromatographia, 2016, 79(3–4): 125-136.

[10] Guo B, Zhang T, Su J, et al. Oxymatrine Targets EGFR^p-Tyr845 and Inhibits EGFR-related Signaling Pathways to Suppress the Proliferation and Invasion of Gastric Cancer Cells[J]. Cancer Chemother Pharmacol, 2015, 75: 353-363.

[11] Zhang S, Wu J, Wang H, et al. Liposomal Oxymatrine in Hepatic Fibrosis Treatment: Formulation, in vitro and in vivo Assessment[J]. Aaps Pharmscitech, 2014, 15(3): 620-629.

[12] Deng Y. Studies on the Encapsulation of Oxymatrine into Liposomes by Ethanol Injection and pH Gradient Method[J]. Drug Development & Industrial Pharmacy, 2006, 32(7): 791-797.

[13] Choi C, Lee HY, Jeong YI, et al. Synthesis of Methoxy poly(ethylene glycol)-b -poly(dl-lactide-co-glycolide) Copolymer Via Diselenide Linkage and Fabrication of Ebselen-incorporated Nanoparticles for Radio-responsive drug Delivery[J]. Journal of Industrial & Engineering Chemistry, 2016, 47: 112-120.

[14] Zhou Y, He C, Chen K, et al. A New Method for Evaluating Actual Drug Release Kinetics of Nanoparticles inside Dialysis Devices via Numerical Deconvolution.[J]. Journal of Controlled Release, 2016, 243: 11-20.

[15] Jin N, Zhao YX, Deng SH, et al. Preparation and in vitro Anticancer Activity of Oxymatrine Mixed Micellar Nanoparticles[J]. Die Pharmazie, 2011, 66(7): 506-510.

[16] Danhier F, Feron O, Préat V. To Exploit, the Tumor, Microenvironment: Passive, and Active, Tumor, Targeting, of Nanocarriers, for Anti-cancer, Drug, Delivery[J]. Journal of Controlled Release, 2010, 148(2): 135-146.

[17] Zhang D, Zou Z, Ren W, et al. Gambogic Acid-loaded PEG-PCL Nanoparticles Act as an Effective Antitumor Agent Against Gastric Cancer[J]. Pharmaceutical Development & Technology, 2017, 23(1): 1-8.

[18] Wang Y, Wan G, Li Z, et al. PEGylated Doxorubicin Nanoparticles Mediated by HN-1 Peptide for Targeted Treatment of Oral Squamous Cell Carcinoma[J]. International Journal of Pharmaceutics, 2017, 525(1): 21-31.

[19] Qin JJ, Wang W, Sarkar S, et al. Oral Delivery of Anti-MDM2 Inhibitor SP141-loaded FcRn-targeted Nanoparticles to Treat Breast Cancer and Metastasis[J]. Journal of Controlled Release, 2016, 237: 101-114.

[20] Wang Y, Chen L, Tan L, et al. PEG-PCL Based Micelle Hydrogels as Oral Docetaxel Delivery Systems for Breast Cancer Therapy[J]. Biomaterials, 2014, 35(25): 6 972-6 985.

[21] Zhang L, Chen Z, Wang H, et al. Preparation and Evaluation of PCL-PEG-PCL polymeric Nanoparticles for Doxorubicin Delivery Against Breast Cancer[J]. Rsc Advances, 2016, 6(60): 54 727-54 737.

[22] Cui FB, Liu Q, Li RT, et al. Enhancement of Radiotherapy Efficacy by miR-200c-loaded Gelatinase-stimuli PEG-Pep-PCL Nanoparticles in Gastric Cancer Cells[J]. International Journal of Nanomedicine, 2014, 9(1): 2 345-2 358.

[23] Meng F, Hiemstra C, Engbers GHM, et al. Biodegradable Polymer-somes[J]. Macromolecules, 2003, 36(9): 3 004-3 006.

[24] Katz JS, Levine DH, Davis KP, et al. Membrane Stabilization of Biodegradable Polymersomes[J]. Langmuir the Acs Journal of Surfaces & Colloids, 2009, 25(8): 4 429-4 434.

[25] Zhang D, Chen K, Wu L, et al. Synthesis and Characterization of PVA-HA-Silk Composite Hydrogel by Orthogonal Experiment[J]. Journal of Bionic Engineering, 2012, 9(2): 234-242.

[26] And RAV, Maguire JF. Polymer Nanocomposites with Prescribed Morphology: Going beyond Nanoparticle-Filled Polymers[J]. Chemistry of Materials, 2007, 19(11): 2 736-2 751.

[27] Prabu P, Chaudhari AA, Ko JA, et al. Cellular Uptake and In Vitro Drug Release Studies on Paclitaxel-Loaded Poly(caprolactone)-Grafted Dextran Copolymeric Nanoparticles[J]. Nanobiotechnology, 2009, 5(1–4): 42-49.

[28] Zhu JS, Xu ZP, Song MQ, et al. Effect of Oxymatrine Combined with Low Dose 5-Fu on Lymphatic Vessel and Microvascular Endothelial Cell Growth of Gastric Cancer in a Severe Combined Immunodeficient Mouse Orthotopic Implantation Model[J]. European Journal of Inflammation, 2011, 9(1): 45-51.

[29] Wang Y, Zheng WY, Menggen DL, et al. Pharmacokinetic Study of OMT Injection in Chinese Healthy Volunteers[J]. Clin. Pharmacol, 2003, 19: 301-305.

[30] Li Z, Liu M, Wang H, et al. Increased Cutaneous Wound Healing Effect of Biodegradable Liposomes Containing Madecassoside: Preparation Optimization, in vitro Dermal Permeation, and in vivo Bioevalu-ation[J]. International Journal of Nanomedicine, 2016, 11: 2 995-3 007.

[31] Sulheim E, Baghirov H, Haartman E, et al. Cellular Uptake and Intra-cellular Degradation of Poly(Alkyl Cyanoacrylate) Nanoparticles[J]. Journal of Nanobiotechnology, 2016, 14(1): 1-14.